T

The Francis Crick Institute

Biomedical research institute advancing human health

Postdoctoral Fellow - Nurse Lab

Full-TimeUpdated on 10/23/2026Deadline 11/8/26
£47.5k
Mid
PhD
London, UK
In Person
Academic & Institutional ResearchLife Sciences Research

About the job

Requirements
  • A PhD in cell biology, molecular genetics, biochemistry, or a related discipline is required.
  • Strong experimental design and data interpretation skills are required.
  • The ability to independently develop and deliver a research project is required.
  • The ability to work effectively within a multidisciplinary and collaborative research environment is required.
  • Strong scientific communication and presentation skills are required.
  • A proactive, creative, and curious approach to solving challenging biological questions is required.
Responsibilities
  • Lead an independent research project investigating cell cycle regulation.
  • Design and carry out experiments using cell biology, molecular genetics, and biochemical approaches.
  • Analyse CDK regulation and its role in DNA replication, mitosis, and cell cycle control.
  • Develop and apply new experimental approaches, with training provided where required.
  • Collaborate with other lab researchers and contribute to wider lab projects.
  • Communicate research findings through publications and scientific presentations.
  • Support and guide PhD students where appropriate.

About the company

T

The Francis Crick Institute

View

The Francis Crick Institute is a biomedical research center that advances understanding of human health and disease. It brings together diverse scientists and technicians, providing support and freedom to pursue ambitious, multidisciplinary projects. Researchers at the Crick explore fundamental biology to answer questions about how life works and how this knowledge can improve health, with partners helping to turn discovery into real-world applications. The institute operates through collaborative teams, shared facilities, and a culture that connects discovery to application, aiming to train the next generation of science leaders. Its goal is to expand knowledge of human biology and translate discoveries into better health outcomes for society.

Company Size

1,001-5,000

Company Stage

Grant

Total Funding

$1.3B

Headquarters

London, United Kingdom

Founded

2011

Get referred to The Francis Crick Institute

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Headcount rose to 1,766 by March 2026, and hiring stayed active.
  • Myricx agreed to a Novartis acquisition worth up to US$1.5 billion in July 2026.
  • Crick launched ALTx in February 2026, backed by Syncona and Cancer Research Horizons.

What critics are saying

  • Merck vacated Crick labs by December 2025, cutting anchor-industry demand and fee income.
  • The 2025 statutory deficit hit £8.6 million, despite £246.2 million income.
  • UKRI still owns 41.9%; funding dependence exposes Crick to government austerity by 2027.

What makes The Francis Crick Institute unique

  • Edith Heard brings EMBL-scale leadership to Crick’s dense, multidisciplinary campus.
  • Five new group leaders in 2026 span AI, neuroscience, cardiovascular science, metabolism, cell biology.
  • Crick-backed ALTx and Myricx show a strong discovery-to-spinout commercialization engine.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Paid Vacation
  • Mental Health Support
  • Back-up care for dependents
  • Childcare Support
  • Annual Leave Purchase Options
  • Gym Membership
  • Commuter Benefits
  • Employee Discounts

Growth & Insights and Company News

6 month growth

14%

1 year growth

15%

2 year growth

15%
Eventscribe
Aug 28th, 2026
SLAS2022

Research FellowThe Francis Crick InstituteLondon, England, United Kingdom

Tech.eu
Jul 8th, 2026
Respiro Diagnostics raises $1.3M to develop breath-based lung cancer diagnostics

Respiro Diagnostics, a UK startup developing breath-based diagnostics for lung diseases, has raised £1 million in pre-seed funding led by Zinc Venture Capital and SFC Capital. Amadeus Capital Partners, the Conception X Angel Syndicate, KQ Labs through the Francis Crick Institute, strategic angel investors and Innovate UK also participated. Founded by Alison Quinn and Dr Theo Issitt, Respiro is developing a non-invasive platform that analyses DNA, RNA and proteins from exhaled breath to detect lung cancer and other respiratory diseases. The technology provides an alternative to invasive tissue biopsies. Respiro has completed proof-of-concept testing in mesothelioma patients and plans to begin its first clinical study in lung cancer patients at Aalborg University Hospital in Denmark in September 2026. The funding will support clinical research and further development of its breath collection device and laboratory platform.

Syncona Limited
Feb 13th, 2026
ALTx Therapeutics launches into the Slingshot accelerator with £12.55 million of funding

Based on the pioneering work of British scientist Simon Boulton, ALTx leverages fundamental insights in cancer cell immortalisation to develop novel treatments for cancer.

PR Newswire
Jan 12th, 2026
PulseAI raises seed funding to scale AI-powered ECG diagnostics and pursue FDA clearance

PulseAI, a Belfast-based cardiac diagnostics company, has closed its seed funding round led by Innovation Ulster Limited, with participation from The Mortara Group and The Francis Crick Institute. The investment will support scaling of its AI-ECG technology and pursuing US FDA 510(k) clearance. The company's platform addresses challenges in interpreting the 300 million ECGs performed annually worldwide, offering clinical decision support for primary and acute care settings. Dr Justin Mortara, former CEO of Mortara Instruments, will join as board chair. Funding will accelerate FDA regulatory advancement, clinical validation across diverse populations, product development for enterprise integration, and partnerships with device manufacturers and hospital networks. The technology has been trained on large-scale ECG datasets and validated with leading institutions across Europe and the United States.

King's College London
Mar 31st, 2025
Discover King's spinouts

Explore our portfolio of spinouts launched by King’s researchers.